ICU Medical, Inc. (ICUI)

ICU Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2,320	2,382	2,259	2,280	1,316	1,271
Revenue	2,320	2,382	2,259	2,280	1,316	1,271
Revenue Growth (YoY)	-0.84%	5.44%	-0.92%	73.21%	3.56%	0.38%
Cost of Revenue	1,474	1,557	1,519	1,582	824.82	809.51
Gross Profit	846.31	824.78	739.87	697.76	491.49	461.5
Selling, General & Admin	628.25	638.76	606.69	608.35	302.58	283.95
Research & Development	88.76	88.62	85.34	92.98	47.5	42.95
Operating Expenses	717.01	727.38	692.04	701.33	350.08	326.9
Operating Income	129.3	97.41	47.84	-3.57	141.41	134.6
Interest Expense	-96.75	-106.54	-102.73	-70.81	-0.86	-1.75
Interest & Investment Income	10.9	10.79	7.51	4.43	2.84	3.68
Currency Exchange Gain (Loss)	-2.62	-9.79	-5.92	-5.78	-1.02	-
Other Non Operating Income (Expenses)	-2.56	-4.92	-2.43	3.2	0.63	2.81
EBT Excluding Unusual Items	39.57	-13.06	-55.74	-72.53	143	139.33
Merger & Restructuring Charges	-55.82	-59.84	-41.26	-71.42	-18.04	-28.41
Gain (Loss) on Sale of Assets	41.52	-1.61	-0.15	-2.55	-1.65	1.77
Other Unusual Items	1.41	5.4	16.25	32.09	-0.13	-15.2
Pretax Income	29.77	-66.01	-78.3	-114.41	123.19	97.49
Income Tax Expense	37.14	51.68	-48.64	-40.12	20.05	10.62
Net Income	-7.36	-117.69	-29.66	-74.29	103.14	86.87
Net Income to Common	-7.36	-117.69	-29.66	-74.29	103.14	86.87
Net Income Growth	-	-	-	-	18.72%	-14.02%
Shares Outstanding (Basic)	25	24	24	24	21	21
Shares Outstanding (Diluted)	25	24	24	24	22	22
Shares Change (YoY)	1.20%	1.23%	0.93%	9.58%	0.88%	0.21%
EPS (Basic)	-0.30	-4.83	-1.23	-3.11	4.86	4.16
EPS (Diluted)	-0.31	-4.83	-1.23	-3.11	4.74	4.02
EPS Growth	-	-	-	-	17.91%	-14.29%
Free Cash Flow	71.96	124.66	82.31	-152.44	199	130.75
Free Cash Flow Per Share	2.93	5.11	3.42	-6.39	9.14	6.06
Gross Margin	36.47%	34.63%	32.75%	30.60%	37.34%	36.31%
Operating Margin	5.57%	4.09%	2.12%	-0.16%	10.74%	10.59%
Profit Margin	-0.32%	-4.94%	-1.31%	-3.26%	7.83%	6.83%
Free Cash Flow Margin	3.10%	5.23%	3.64%	-6.69%	15.12%	10.29%
EBITDA	332.21	316.92	276.61	231.58	231.11	220.23
EBITDA Margin	14.32%	13.30%	12.24%	10.16%	17.56%	17.33%
D&A For EBITDA	202.91	219.51	228.77	235.15	89.7	85.63
EBIT	129.3	97.41	47.84	-3.57	141.41	134.6
EBIT Margin	5.57%	4.09%	2.12%	-0.16%	10.74%	10.59%
Effective Tax Rate	124.73%	-	-	-	16.28%	10.90%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q